ST2 is the ideal biomarker for serial testing. Levels of the biomarker ST2 change rapidly in response to changes in a heart failure patient’s condition, helping you to quickly adjust care.
ST2 significantly improves the accuracy of patient prognosis over natriuretic peptide markersand is not adversely affected by confounding factors such as age, body mass index, smoking, anemia and impaired renal function.
ST2 has a single cutpoint, removing any guesswork. If your patient’s ST2 level is over 35*, that’s a warning sign.
ST2 can satisfy your hunger for a serial biomarker. Don’t start your morning without it. To learn more about the Presage® ST2 Assay, go to www. criticaldiagnostics.com or call 1-877-700-1250.